Articles | EuroIntervention

Trial Design

10.4244/EIJ-D-23-00567 • Jan 10, 2024

A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trial

Foley M, Rajkumar C, Ahmed-Jushuf F, Simader F, Pathimagaraj RH, Nijjer S, Sen S, Petraco R, Clesham G, Johnson T, Harrell Jr FE, Kellman P, Francis D, Shun-Shin M, Howard J, Cole G, Al-Lamee R

free

Letter to the editor

10.4244/EIJ-D-23-00830 • Jan 1, 2024

Letter: Due to the lack of significant mortality benefit along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged

Movahed MR

free

Reply to the letter to the editor

10.4244/EIJ-D-23-00857 • Jan 1, 2024

Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged

Werner G, Hildick-Smith D

free

EAPCI Column

Jan 1, 2024

EAPCI membership: why should you become an EAPCI member? Message from Emanuele Barbato, EAPCI President

free

Editorial

Jan 1, 2024

EuroIntervention: the dawn of a new era

Capodanno D

free

Editorial

10.4244/EIJ-E-23-00062 • Jan 1, 2024

Hybrid coronary revascularisation: the best or the worst of both worlds?

Gaudino M, Sandner S

free

Editorial

10.4244/EIJ-E-23-00064 • Jan 1, 2024

Robotic-assisted percutaneous coronary intervention: the future or the past?

Durand E, Eltchaninoff H

free

Editorial

10.4244/EIJ-E-23-00051 • Jan 1, 2024

Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis

Gargiulo G, Giacoppo D

free

Editorial

10.4244/EIJ-E-23-00056 • Jan 1, 2024

The first cut is the deepest – a solution for treating calcified lesions?

Mashayekhi K, Moos S

free

Editorial

10.4244/EIJ-E-23-00058 • Jan 1, 2024

Real-world evidence with the ACURATE neo2: a prelude to the ACURATE IDE trial

Windecker S, Tomii D

free

Debate

10.4244/EIJ-E-23-00023 • Jan 1, 2024

Observational studies play little role in guiding evidence-based medicine: pros and cons

Steg P, Feldman L, Omerovic E

free

State-of-the-Art

10.4244/EIJ-D-23-00606 • Jan 1, 2024

Targeting inflammation in atherosclerosis: overview, strategy and directions

Waksman R, Merdler I, Case BC, Waksman O, Porto I

free

Original Research

10.4244/EIJ-D-23-00373 • Jan 1, 2024

Long-term clinical outcomes of robotic-assisted surgical coronary artery revascularisation

Dokollari A, Sicouri S, Erten O, Gray WA, Shapiro TA, McGeehin F, Badri M, Coady P, Gnall E, Caroline M, Khan AA, Kjelstrom S, Montone G, Ramlawi B, Wertan MA, Sutter FP, Torregrossa G

free

Original Research

10.4244/EIJ-D-23-00375 • Jan 1, 2024

Procedural and one-year outcomes of robotic-assisted versus manual percutaneous coronary intervention

Bay B, Kiwus LM, Goßling A, Koester L, Blaum C, Schrage B, Clemmensen P, Blankenberg S, Waldeyer C, Seiffert M, Brunner FJ

free

Original Research

10.4244/EIJ-D-22-00809 • Jan 1, 2024

Ultrasound guidance for transfemoral access in coronary procedures: an individual participant-level data meta analysis from the femoral ultrasound trialist collaboration

d'Entremont M, Alrashidi S, Seto AH, Nguyen P, Marquis-Gravel G, Abu-Fadel M, Juergens C, Tessier P, Lemaire-Paquette S, Heenan L, Skuriat E, Tyrwhitt J, Couture ÉL, Bérubé S, Jolly S

free